Experts say we’re in a golden age for treating chronic kidney disease, with new drugs like Ozempic yielding major results.

The blockbuster weight loss drug semaglutide can cut the progression of diabetic kidney disease, according to its manufacturer Novo Nordisk, adding to growing evidence that the medication has ...

The drug finerenone has a positive effect on patients with type 1 diabetes and chronic kidney disease. The drug reduces the amount of proteins excreted in the urine of these patients. This reduction ...

The kidneys are vital organs that play a significant role in maintaining the body’s internal environment. They filter about 200 quarts of blood daily, removing waste products and excess fluids through ...

A new study suggests that individuals with type 2 diabetes can lower their risk of kidney disease by increasing their intake ...

eGFRdiff and GDF-15 are independent predictors of chronic kidney disease progression and mortality in diabetes, highlighting their potential for risk stratification in clinical practice. Kidney ...

Semaglutide significantly lowered the rate of complications in individuals with diabetes and chronic kidney disease. People on semaglutide saw an 18 percent drop in their risk of cardiovascular ...

Diabetes is the most common cause of chronic kidney disease (CKD). Around 33 percent of adults with diabetes also have CKD. When diabetes causes CKD, its sometimes called diabetic kidney disease.

In this Diabetes in Real Life column, Susan Weiner, MS, RDN, CDN, CDCES, FADCES, talks with Colleen Dawkins, FNP-C, RD, CSOWM ...

ROCHESTER — A change in federal guidelines for living organ donation opens the door for people with well-controlled Type 2 diabetes to become kidney donors. "I think this is a very significant shift ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...